Advertisement
Screener

WEST PHARMACEUTICAL SERVICES, INC. (WST) Restructuring Charges

2.8 / 5 stars · 68/120 Roast Me

WEST PHARMACEUTICAL SERVICES, INC. Restructuring Charges

WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Restructuring Charges of $2.50 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-10-23.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:RestructuringCharges · last filed 2025-10-23

  • WEST PHARMACEUTICAL SERVICES, INC. restructuring charges for the quarter ending 2025-09-30 was $900.00K.
  • WEST PHARMACEUTICAL SERVICES, INC. restructuring charges for the quarter ending 2025-06-30 was $800.00K.
  • WEST PHARMACEUTICAL SERVICES, INC. restructuring charges for the quarter ending 2025-03-31 was $800.00K.
  • WEST PHARMACEUTICAL SERVICES, INC. restructuring charges for the quarter ending 2024-09-30 was -$2.50M.
  • WEST PHARMACEUTICAL SERVICES, INC. restructuring charges for fiscal 2012 was $2.10M, a 60.38% decline from fiscal 2011.
  • WEST PHARMACEUTICAL SERVICES, INC. restructuring charges for fiscal 2011 was $5.30M.
Period endRestructuring Charges 3 monthRestructuring Charges 6 monthRestructuring Charges 9 monthRestructuring Charges 9 month as first filedRestructuring Charges 12 month
2025-09-30$900.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23
$1.70M
derived: sum of 2 quarters · filed 2025-10-23
$2.50M
10-Q · filed 2025-10-23
2025-06-30$800.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24
$1.60M
10-Q · filed 2025-07-24
2025-03-31$800.00K
10-Q · filed 2025-04-24
2024-09-30-$2.50M
10-Q · filed 2024-10-24
-$2.50M
derived: sum of 2 quarters · filed 2025-07-24
$0.00
10-Q · filed 2025-10-23
-$2.50M
10-Q · filed 2024-10-24
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24
$0.00
10-Q · filed 2025-07-24
2024-03-31$0.00
10-Q · filed 2025-04-24
2023-09-30$0.00
10-Q · filed 2024-10-24
-$800.00K
10-Q · filed 2024-10-24
2020-06-30$2.20M
10-Q · filed 2020-07-24
$2.20M
10-Q · filed 2020-07-24
2019-09-30$1.80M
10-Q · filed 2019-10-29
$3.20M
derived: sum of 2 quarters · filed 2020-07-24
$3.80M
10-Q · filed 2019-10-29
2019-06-30$1.40M
10-Q · filed 2020-07-24
$2.00M
10-Q · filed 2020-07-24
2019-03-31$600.00K
10-Q · filed 2020-04-24
2018-09-30$1.20M
10-Q · filed 2019-10-29
$3.40M
derived: sum of 2 quarters · filed 2019-10-29
$6.70M
10-Q · filed 2019-10-29
2018-06-30$2.20M
10-Q · filed 2019-07-29
$5.50M
10-Q · filed 2019-07-29
2018-03-31$3.30M
10-Q · filed 2019-05-08
2016-12-31$2.70M
derived: 10-Q 12 month − 10-Q 9 month · filed 2017-05-05
$5.00M
derived: sum of 2 quarters · filed 2017-10-31
$3.50M
derived: sum of 3 quarters · filed 2017-10-31
$26.40M
10-Q · filed 2017-05-05
2016-09-30$2.30M
10-Q · filed 2017-10-31
$800.00K
derived: sum of 2 quarters · filed 2017-10-31
$23.70M
10-Q · filed 2017-10-31
2016-06-30-$1.50M
10-Q · filed 2017-08-01
$21.40M
10-Q · filed 2017-08-01
2016-03-31$22.90M
10-Q · filed 2017-05-05
2012-12-31$300.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27
$1.40M
derived: sum of 2 quarters · filed 2014-02-27
$2.10M
10-K · filed 2014-02-27
2012-09-30$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
$1.80M
10-Q · filed 2012-11-05
2012-06-30$700.00K
10-Q · filed 2012-08-06
2011-12-31$5.30M
10-K · filed 2013-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
DEXCOM INC (DXCM)United States$33.004B25.42
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44